Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. Drugmakers have warned that a recent rise in the UK’s medicine sales tax has left the country “uninvestable”, as the […]
Higher medicine sales tax makes UK ‘uninvestable’, drugmakers warn Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Drugmaker Hikma is in talks with partners across the world to prepare to sell a generic version of Ozempic and
Hikma races to launch generic versions of blockbuster obesity drugs Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK has proposed increasing pay for its chief executive Emma Walmsley to as much as £21.6mn a year, as London-listed
GSK proposes raising chief’s pay to as much as £21.6mn a year Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more
Ken Griffin’s Citadel bets £300mn against drugmaker GSK Read More »
Unlock the White House Watch newsletter for free Your guide to what the 2024 US election means for Washington and the world Donald Trump’s transition team is pushing to pull the US out of the World Health Organization on the
Donald Trump’s transition team seeks to pull US out of WHO ‘on day one’ Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk, one of Europe’s largest companies, lost more than a quarter of its value on Friday after its latest
Novo Nordisk shares tumble as weight-loss drug trial data disappoints Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The alleged Chinese spy linked to Prince Andrew has been publicly named as Tengbo Yang after a judge lifted an
Court names alleged Chinese spy linked to Prince Andrew Read More »
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Carlyle-backed investor Abingworth is tapping investors for a fund worth up to $1.5bn to bankroll clinical trials, as it pioneers
Carlyle-backed life sciences investor launches $1.5bn clinical trials fund Read More »
